Company: IMNN
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001641172-25-013088
Chunk: 32

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 32
---
 to the Existing Warrant Holders an aggregate of 2,921,000 shares of Common Stock (the “ Warrant Exchange Shares”), on a one-for-one basis, in exchange for shares issuable under the Existing Warrants (the “ Warrant Exchange”). The Warrant Exchange closed on May 13, 2025. The number of Warrant Exchange Shares issued pursuant to the Exchange Agreement represented 19.98% of the shares of Common Stock outstanding as of the date of the Exchange Agreement. The Warrant Exchange was completed, and the Warrant Exchange Shares were issued in reliance on, the exemption from registration provided by Section 3(a)(9) of the Securities Act, on the basis that (a) the Warrant Exchange Shares are being issued in exchange for other outstanding securities of the Company; (b) there will be no additional consideration delivered by the Existing Warrant Holders in connection with the Warrant Exchange; and (c) there were no commissions or other remuneration paid by the Company in connection with the Warrant Exchange.

| II-2 |

On May 23, 2025, the Company entered into the Purchase Agreement with certain purchasers for the issuance and sale in a Private Placement of (i) 2,777,779 shares of Common Stock, (ii) Pre-Funded Warrants to purchase up to 4,444,444 shares of Common Stock, at an exercise price of $0.0001 per share, and (iii) Common Warrants to purchase up to 14,444,446 shares of Common Stock, at an exercise price of $0.45 per share. The Private Placement was priced at the market at a combined purchase price per share and accompanying Common Warrant of $0.45 and closed on May 27, 2025. In connection with the Private Placement, the Company issued to designees of H.C. Wainwright & Co., LLC the Placement Agent Warrants to purchase up to an aggregate of 361,111 shares of Common Stock at an exercise price equal to $0.5625 per share. The issuance of the shares of Common Stock and the Warrants were, and the shares of Common Stock issuable upon the exercise of the Warrants will be, issued in reliance on the exemptions from registration provided by Section 4(a)(2) under the Securities Act and/or Regulation D promulgated thereunder.

Item 16. Exhibits and Financial Statement Schedules

(a) The exhibits set forth below have been or are